Ask Dr. Hallberg: Drug maker to stop paying physicians to promote products
Go Deeper.
Create an account or log in to save stories.
Like this?
Thanks for liking this story! We have added it to a list of your favorite stories.
GlaxoSmithKline, one of the world's biggest drug makers, has decided to stop paying physicians who promote or speak on behalf of their products.
The move may force other companies to act, since the entire drugs industry has been under fire for aggressive marketing tactics in recent years.
"Where GSK leads we must hope that other companies will follow," Fiona Godlee, editor of the British Medical Journal and an influential campaigner against undue industry influence in medical practice, told Reuters.
"But there is a long way to go if we are to truly to extricate medicine from commercial influence. Doctors and their societies have been too ready to compromise themselves."
Dr. Jon Hallberg, a physician in family medicine at the University of Minnesota and a regular medical analyst on All Things Considered, has long been following the issue and discussed it with MPR News' Tom Crann. Click play above to hear their conversation.
Turn Up Your Support
MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all.